ADAMTS9 and nonpapillary renal cell carcinoma: Conversely, ADAMTS9-AS2 knockdown (Figure 5C, P<0.05) and miR-27a-3p overexpression (Figure 5D, P<0.05) resulted in the insensitivity of ccRCC cells to increased 5-Fu and, moreover, partially alleviated the growth inhibition of ccRCC cells.